SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-022964
Filing Date
2021-09-17
Accepted
2021-09-17 07:00:36
Documents
17
Period of Report
2021-09-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51290
2 ex4-1.htm EX-4.1 35431
3 ex10-1.htm EX-10.1 225361
4 ex99-1.htm EX-99.1 19152
5 ex99-1_001.jpg GRAPHIC 2546
6 ex99-1_002.jpg GRAPHIC 2546
  Complete submission text file 0001493152-21-022964.txt   553897

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE envb-20210916.xsd EX-101.SCH 3021
8 XBRL LABEL FILE envb-20210916_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE envb-20210916_pre.xml EX-101.PRE 22356
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3743
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 211259217
SIC: 2834 Pharmaceutical Preparations